MedWatch Daily Digest: Covid and young adults, Vitamin D and more

Medical Watch

For Tuesday, May 11, WGN’s Medical Reporter Dina Bair has the latest on new information including:

  • University of Alberta virologists tested the medication and found it attacks SARS CoV-2, the virus that causes COVID-19. It works by changing the viral genome of the virus – -essentially creating an error catastrophe for the replicating germ.
  • Some sobering news when it comes to serious Covid infections. Eight out of 10 people hospitalized with COVID-19 develop neurological problems.
    A study by University of Pittsburgh researchers found neurological ramifications in active infection and among survivors.
  • An ultrasensitive test can diagnose Covid and the flu with one swab.
    Developed by University of California Santa Cruz scientists, the chip based antigen test identifies SAR CoV-2 and Influenza-A.
  • There is a demographic shift in serious COVID-19 cases to report. After spending much of the past year treating elderly patients, doctors are now seeing more young and middle-aged adults.
  • A study out of Brazil concludes high doses of Vitamin D don’t have any effect on people in the hospital suffering with moderate to severe COVID-19 symptoms. 
  • There’s a big connection between the gut and the brain. It turns out microorganisms living in the gut can affect mood and may even provide links to anxiety and depression. A new study suggests a type of prebiotic could reduce anxiety in some females in late adolescence through changes in their gut microorganisms.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Listen to the Bair Facts on Health

Get the real facts on everything from diet trends to cutting-edge treatments, brought to you by Dina Bair and actual experts, so you can ignore the noise on social media and make informed decisions about your health.

Subscribe to the podcast

Apple Podcasts

Pocket Casts




Latest News

More News